New malaria pill takes first step: is it safe for humans?
NCT ID NCT06854042
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This very early study is testing a new drug called E1018 in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single oral dose of either E1018 or a placebo. The goal is not to treat malaria, but to gather initial safety data before any future studies in patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- E1018
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PPD Development, LP
Austin, Texas, 78744, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Can a pill make your blood deadly to malaria mosquitoes?
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?